As a result, TNF-a plays a complex role in CTCL pathogenesis along with other cytokines, such as IL-7, IL-12, and 15, by allowing neoplastic cells to gain advantages against immune system antitumor action. This evidence concerns the gene TNF and primary cutaneous T-cell non-Hodgkin lymphoma.